Mentice AB (publ)

OM:MNTC Stock Report

Market Cap: SEK 521.6m

Mentice Valuation

Is MNTC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MNTC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
SEK 87.60
Fair Value
76.7% undervalued intrinsic discount
4
Number of Analysts

Below Fair Value: MNTC (SEK20.4) is trading below our estimate of fair value (SEK87.6)

Significantly Below Fair Value: MNTC is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MNTC?

Key metric: As MNTC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for MNTC. This is calculated by dividing MNTC's market cap by their current revenue.
What is MNTC's PS Ratio?
PS Ratio1.8x
SalesSEK 291.81m
Market CapSEK 521.60m

Price to Sales Ratio vs Peers

How does MNTC's PS Ratio compare to its peers?

The above table shows the PS ratio for MNTC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average5.3x
SYNT SyntheticMR
12.2x18.8%SEK 1.2b
PTRK Physitrack
1.1x10.3%SEK 195.1m
CARA Carasent
6.6x15.8%SEK 1.8b
MEDHLP Medhelp Care Aktiebolag
1.2x5.4%SEK 105.3m
MNTC Mentice
1.8x17.5%SEK 521.6m

Price-To-Sales vs Peers: MNTC is good value based on its Price-To-Sales Ratio (1.8x) compared to the peer average (5.3x).

Price to Sales Ratio vs Industry

How does MNTC's PS Ratio compare vs other companies in the European Healthcare Services Industry?

6 CompaniesPrice / SalesEstimated GrowthMarket Cap
MNTC 1.8xIndustry Avg. 2.0xNo. of Companies7PS0246810+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: MNTC is good value based on its Price-To-Sales Ratio (1.8x) compared to the European Healthcare Services industry average (2x).

Price to Sales Ratio vs Fair Ratio

What is MNTC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MNTC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.8x
Fair PS Ratio4.3x

Price-To-Sales vs Fair Ratio: MNTC is good value based on its Price-To-Sales Ratio (1.8x) compared to the estimated Fair Price-To-Sales Ratio (4.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MNTC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 20.40
SEK 39.88
+95.5%
29.1%SEK 58.00SEK 26.00n/a4
Apr ’26SEK 21.60
SEK 39.88
+84.6%
29.1%SEK 58.00SEK 26.00n/a4
Mar ’26SEK 21.40
SEK 41.75
+95.1%
27.2%SEK 58.00SEK 26.00n/a4
Feb ’26SEK 26.00
SEK 42.67
+64.1%
30.9%SEK 60.00SEK 28.00n/a3
Jan ’26SEK 25.50
SEK 42.67
+67.3%
30.9%SEK 60.00SEK 28.00n/a3
Dec ’25SEK 25.90
SEK 42.67
+64.7%
30.9%SEK 60.00SEK 28.00n/a3
Nov ’25SEK 28.60
SEK 47.67
+66.7%
23.8%SEK 63.00SEK 36.00n/a3
Oct ’25SEK 27.30
SEK 47.67
+74.6%
23.8%SEK 63.00SEK 36.00n/a3
Sep ’25SEK 25.30
SEK 47.67
+88.4%
23.8%SEK 63.00SEK 36.00n/a3
Aug ’25SEK 33.50
SEK 47.67
+42.3%
23.8%SEK 63.00SEK 36.00n/a3
Jul ’25SEK 29.20
SEK 45.00
+54.1%
25.7%SEK 61.00SEK 34.00n/a3
Jun ’25SEK 27.00
SEK 45.00
+66.7%
25.7%SEK 61.00SEK 34.00n/a3
May ’25SEK 35.60
SEK 55.33
+55.4%
14.0%SEK 65.00SEK 46.00SEK 20.703
Apr ’25SEK 33.30
SEK 55.33
+66.2%
14.0%SEK 65.00SEK 46.00SEK 21.603
Mar ’25SEK 37.60
SEK 60.67
+61.3%
9.0%SEK 65.00SEK 53.00SEK 21.403
Feb ’25SEK 47.70
SEK 64.67
+35.6%
5.1%SEK 67.00SEK 60.00SEK 26.003
Jan ’25SEK 47.70
SEK 67.17
+40.8%
8.8%SEK 74.50SEK 60.00SEK 25.503
Dec ’24SEK 39.90
SEK 67.17
+68.3%
8.8%SEK 74.50SEK 60.00SEK 25.903
Nov ’24SEK 32.60
SEK 67.17
+106.0%
8.8%SEK 74.50SEK 60.00SEK 28.603
Oct ’24SEK 32.70
SEK 67.17
+105.4%
7.7%SEK 74.50SEK 63.00SEK 27.303
Sep ’24SEK 37.00
SEK 67.17
+81.5%
7.7%SEK 74.50SEK 63.00SEK 25.303
Aug ’24SEK 43.50
SEK 67.17
+54.4%
7.7%SEK 74.50SEK 63.00SEK 33.503
Jul ’24SEK 37.50
SEK 66.17
+76.4%
9.6%SEK 74.50SEK 59.00SEK 29.203
Jun ’24SEK 41.70
SEK 66.17
+58.7%
9.6%SEK 74.50SEK 59.00SEK 27.003
May ’24SEK 42.40
SEK 66.17
+56.1%
9.6%SEK 74.50SEK 59.00SEK 35.603
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
SEK 39.88
Fair Value
48.8% undervalued intrinsic discount
4
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 21:23
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mentice AB (publ) is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rikard EngbergCarnegie Commissioned Research
Christian LeePareto Securities
Rikard EngbergPenser Access